Literature DB >> 23212355

[Ophthalmological screening for retinopathy of prematurity].

I Oberacher-Velten1, H Segerer, H Helbig.   

Abstract

Retinopathy of prematurity (ROP) is one of the three leading causes of legal blindness in childhood in developed countries. Adequate screening is one of the most important steps towards successful treatment. During the last decades, international and national guidelines for ROP screening have been continually updated. These guidelines correspond to progress in neonatal care and to a better understanding of the relationship between different neonatal parameters and the risk of developing ROP. The present article surveys ROP classification, the current national and international guidelines and new aspects of ROP screening.

Entities:  

Mesh:

Year:  2012        PMID: 23212355     DOI: 10.1007/s00347-012-2617-9

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  27 in total

1.  Vascularization of the human fetal retina: roles of vasculogenesis and angiogenesis.

Authors:  S Hughes; H Yang; T Chan-Ling
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-04       Impact factor: 4.799

2.  Supplemental Therapeutic Oxygen for Prethreshold Retinopathy Of Prematurity (STOP-ROP), a randomized, controlled trial. I: primary outcomes.

Authors: 
Journal:  Pediatrics       Date:  2000-02       Impact factor: 7.124

Review 3.  The International Classification of Retinopathy of Prematurity revisited.

Authors: 
Journal:  Arch Ophthalmol       Date:  2005-07

4.  Telemedical retinopathy of prematurity diagnosis: accuracy, reliability, and image quality.

Authors:  Michael F Chiang; Lu Wang; Mihai Busuioc; Yunling E Du; Patrick Chan; Steven A Kane; Thomas C Lee; David J Weissgold; Audina M Berrocal; Osode Coki; John T Flynn; Justin Starren
Journal:  Arch Ophthalmol       Date:  2007-11

5.  [Guidelines for ophthalmologic screening of premature infants].

Authors:  C Jandeck; U Kellner; B Lorenz; V Seiberth
Journal:  Ophthalmologe       Date:  2008-10       Impact factor: 1.059

6.  Maternal and neonatal factors associated with poor early weight gain and later retinopathy of prematurity.

Authors:  Margareta Hök Wikstrand; Anna-Lena Hård; Aimon Niklasson; Lois Smith; Chatarina Löfqvist; Ann Hellström
Journal:  Acta Paediatr       Date:  2011-07-18       Impact factor: 2.299

7.  Longitudinal postnatal weight measurements for the prediction of retinopathy of prematurity.

Authors:  Carolyn Wu; Deborah K Vanderveen; Ann Hellström; Chatarina Löfqvist; Lois E H Smith
Journal:  Arch Ophthalmol       Date:  2010-04

8.  An international classification of retinopathy of prematurity. II. The classification of retinal detachment. The International Committee for the Classification of the Late Stages of Retinopathy of Prematurity.

Authors: 
Journal:  Arch Ophthalmol       Date:  1987-07

9.  Retinopathy of prematurity in practice. I: screening for threshold disease.

Authors:  R Brennan; L Gnanaraj; D G Cottrell
Journal:  Eye (Lond)       Date:  2003-03       Impact factor: 3.775

10.  Treatment for retinopathy of prematurity in Denmark in a ten-year period (1996 2005): is the incidence increasing?

Authors:  Carina Slidsborg; Henrik Bom Olesen; Peter Koch Jensen; Hanne Jensen; Kamilla Rothe Nissen; Gorm Greisen; Steen Rasmussen; Hans Callø Fledelius; Morten la Cour
Journal:  Pediatrics       Date:  2008-01       Impact factor: 7.124

View more
  3 in total

1.  [Laser treatment or intravitreal VEGF inhibition for aggressive posterior retinopathy of prematurity?].

Authors:  T Barth; K Hufendiek; H Helbig; I Oberacher-Velten
Journal:  Ophthalmologe       Date:  2015-06       Impact factor: 1.059

2.  [Retinopathy of prematurity : Current developments in therapy and epidemiology].

Authors:  T U Krohne
Journal:  Ophthalmologe       Date:  2018-06       Impact factor: 1.059

3.  Congenital blindness and visual impairment cause infection or non infection.

Authors:  Mirjana A Janicijevic-Petrovic; Tatjana S Sarenac-Vulovic; Katarina M Janicijevic; Dragan I Vujic; Dejan D Vulovic
Journal:  Mater Sociomed       Date:  2013
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.